Annual report pursuant to Section 13 and 15(d)

Revision of Prior Period Financial Statements - Revised Condensed Consolidated Balance Sheets (Details)

v3.23.1
Revision of Prior Period Financial Statements - Revised Condensed Consolidated Balance Sheets (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Current assets:      
Cash and cash equivalents $ 229,783 $ 307,492 $ 4,704
Restricted cash 0 400  
Accounts receivable, net 31,920 6,477 1,401
Inventory 10,257 2,890 1,586
Current portion of contract assets 2,852 1,459  
Current portion of commission asset 3,384 1,645 562
Prepaid expenses and other current assets 14,388 10,757 1,541
Total current assets 292,584 331,120 9,794
Restricted cash, noncurrent 275 275  
Contract assets, noncurrent 1,386 3,418  
Commission asset, noncurrent 5,655 3,719 1,730
Leased equipment, net 44,707 23,783 10,068
Operating lease right-of-use assets 1,673 0  
Other assets   542 173
Total assets 348,115 362,857 21,765
Current liabilities:      
Accounts payable 18,194 6,045 4,437
Accrued expenses and other current liabilities 11,545 9,551 4,211
Current portion of deferred revenue 18,273 6,599 3,762
Current portion of deferred rent 0 135 $ 11
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]     Total current liabilities
Current portion of financing obligations     $ 227
Current portion of long-term debt 10,000 2,000  
Current portion of operating lease liabilities 1,114 0  
Total current liabilities 59,126 24,330 12,648
Deferred revenue, noncurrent 17,695 2,475 $ 480
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]     Total liabilities
Deferred rent, noncurrent 0 333  
Financing obligation, noncurrent     $ 132
Long-term debt, noncurrent 19,683 7,945 $ 16,432
Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]     Total liabilities
Derivative Liability     $ 1,000
Operating lease liabilities, noncurrent 892 0  
Contingent earn-out liability 14,218 21,206  
Contingently issuable common stock liability 3,392 5,264  
Public warrant liability 6,124 11,030 1
Total liabilities 121,130 72,583 30,693
Stockholders’ equity:      
Preferred stock, $0.0001 par value; 100,000,000 authorized at December 31, 2022 and December 31, 2021; no shares issued and outstanding at December 31, 2022 and December 31, 2021 0 0 1
Common stock, $0.0001 par value; 1,100,000,000 shares authorized at December 31, 2022 and December 31, 2021, 145,204,974 and 142,745,021 shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively 15 14 75,877
Additional paid-in capital 419,190 396,064 10,110
Accumulated other comprehensive income (loss) (10) 0  
Accumulated deficit (192,210) (105,804) (94,916)
Stockholders’ equity 226,985 290,274 (84,805)
Total liabilities and stockholders’ equity $ 348,115 362,857 21,765
As Previously Reported      
Current assets:      
Cash and cash equivalents   307,492 4,704
Restricted cash   400  
Accounts receivable, net   6,477 1,401
Inventory   5,140 2,742
Current portion of contract assets   1,459  
Current portion of commission asset   1,645 562
Prepaid expenses and other current assets   11,047 900
Total current assets   333,660 10,309
Restricted cash, noncurrent   275  
Contract assets, noncurrent   3,418  
Commission asset, noncurrent   3,719 1,730
Leased equipment, net   21,592 9,316
Other assets   401 0
Total assets   363,065 21,355
Current liabilities:      
Accounts payable   6,363 4,437
Accrued expenses and other current liabilities   9,183 3,727
Current portion of deferred revenue   6,690 3,717
Current portion of deferred rent   135 11
Current portion of financing obligations     227
Current portion of long-term debt   2,000  
Total current liabilities   24,371 12,119
Deferred revenue, noncurrent   2,475 480
Deferred rent, noncurrent   333  
Financing obligation, noncurrent     132
Long-term debt, noncurrent   7,945 16,432
Derivative Liability     1,000
Contingent earn-out liability   20,809  
Contingently issuable common stock liability   5,264  
Public warrant liability   11,030 1
Total liabilities   72,227 30,164
Stockholders’ equity:      
Preferred stock, $0.0001 par value; 100,000,000 authorized at December 31, 2022 and December 31, 2021; no shares issued and outstanding at December 31, 2022 and December 31, 2021   0 1
Common stock, $0.0001 par value; 1,100,000,000 shares authorized at December 31, 2022 and December 31, 2021, 145,204,974 and 142,745,021 shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively   14 75,877
Additional paid-in capital   395,563 9,194
Accumulated deficit   (104,739) (93,881)
Stockholders’ equity   290,838 (84,686)
Total liabilities and stockholders’ equity   363,065 21,355
Adjustment      
Current assets:      
Cash and cash equivalents   0 0
Restricted cash   0  
Accounts receivable, net   0 0
Inventory   (2,250) (1,156)
Current portion of contract assets   0  
Current portion of commission asset   0 0
Prepaid expenses and other current assets   (290) 641
Total current assets   (2,540) (515)
Restricted cash, noncurrent   0  
Contract assets, noncurrent   0  
Commission asset, noncurrent   0 0
Leased equipment, net   2,191 752
Other assets   141 173
Total assets   (208) 410
Current liabilities:      
Accounts payable   (318) 0
Accrued expenses and other current liabilities   368 484
Current portion of deferred revenue   (91) 45
Current portion of deferred rent   0 0
Current portion of financing obligations     0
Current portion of long-term debt   0  
Total current liabilities   (41) 529
Deferred revenue, noncurrent   0 0
Deferred rent, noncurrent   0  
Financing obligation, noncurrent     0
Long-term debt, noncurrent   0 0
Derivative Liability     0
Contingent earn-out liability   397  
Contingently issuable common stock liability   0  
Public warrant liability   0 0
Total liabilities   356 529
Stockholders’ equity:      
Preferred stock, $0.0001 par value; 100,000,000 authorized at December 31, 2022 and December 31, 2021; no shares issued and outstanding at December 31, 2022 and December 31, 2021   0 0
Common stock, $0.0001 par value; 1,100,000,000 shares authorized at December 31, 2022 and December 31, 2021, 145,204,974 and 142,745,021 shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively   0 0
Additional paid-in capital   501 916
Accumulated deficit   (1,065) (1,035)
Stockholders’ equity   (564) (119)
Total liabilities and stockholders’ equity   $ (208) $ 410